Actionnariat et activité des initiés pour ADMA Biologics, Inc. (ADMA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $8.90 |
| Capitalisation | $2.1B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-24 | Kestenberg-Messina Kaitlin M. | F-InKind | 3,177 | $27K |
| 2026-07-16 | Kohler Terry | A-Award | 85,130 | |
| 2026-07-16 | Kohler Terry | A-Award | 136,363 | $1.2M |
| 2026-05-27 | Grossman Jerrold B | P-Purchase | 6,400 | $51K |
| 2026-05-12 | Grossman Jerrold B | P-Purchase | 12,500 | $100K |
| 2026-05-11 | Grossman Jerrold B | P-Purchase | 12,500 | $100K |
| 2026-04-01 | Kestenberg-Messina Kaitlin M. | F-InKind | 20,362 | $185K |
| 2026-03-13 | Guiheen Lawrence P. | M-Exempt | 30,000 | $110K |
| 2026-03-17 | Guiheen Lawrence P. | G-Gift | 30,000 | |
| 2026-03-17 | Guiheen Lawrence P. | G-Gift | 30,000 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $9.9M | $43.1M | $22.8M | $26.8M | $55.9M | $51.1M | $86.5M | $51.4M | $103.1M | $87.6M |
| Placements à Court Terme | $5.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $1.0M | $3.9M | $1.4M | $3.5M | $13.2M | $28.6M | $15.5M | $27.4M | $50.0M | $158.4M |
| Stocks | $5.0M | $12.6M | $18.6M | $53.1M | $81.5M | $124.7M | $163.3M | $172.9M | $170.2M | $206.5M |
| Actifs Courants | $21.7M | $63.2M | $44.5M | $85.8M | $153.7M | $208.7M | $270.4M | $257.0M | $331.4M | $466.5M |
| Immobilisations Corporelles | $2.0M | $30.5M | $30.1M | $33.0M | $45.9M | $58.2M | $68.7M | $63.5M | $63.3M | $71.7M |
| Goodwill | 0 | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M |
| Actifs Incorporels | 0 | $4.8M | $4.0M | $3.2M | $2.4M | $1.7M | $1.0M | $499000 | $460000 | $632000 |
| Actifs Totaux | $23.7M | $108.0M | $88.9M | $127.1M | $207.7M | $276.3M | $348.5M | $329.2M | $488.7M | $624.2M |
| Dettes Fournisseurs | $2.6M | $5.9M | $5.9M | $9.2M | $11.1M | $12.4M | $13.2M | $15.7M | $20.2M | $22.5M |
| Dette à Court Terme | $6.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.8M |
| Passifs Courants | $11.2M | $9.4M | $9.6M | $14.0M | $19.9M | $30.4M | $39.3M | $49.8M | $55.5M | $69.5M |
| Dette à Long Terme | $14.1M | $43.0M | $44.1M | $83.2M | $93.0M | $94.9M | $142.8M | $130.6M | $72.3M | $69.3M |
| Passifs Totaux | $28.1M | $67.7M | $69.1M | $100.9M | $119.4M | $135.1M | $196.5M | $194.0M | $139.7M | $146.9M |
| Réserves | -$106.9M | -$150.7M | -$216.4M | -$264.7M | -$340.5M | -$412.1M | -$478.0M | -$506.3M | -$308.6M | -$161.7M |
| Capitaux Propres | -$4.5M | $40.3M | $19.8M | $26.2M | $88.2M | $141.2M | $152.0M | $135.2M | $349.0M | $477.3M |
| Dette Totale | $20.3M | $43.0M | $44.2M | $84.7M | $97.7M | $102.9M | $154.4M | $141.4M | $82.1M | $79.9M |
| Dette Nette | $5.0M | -$136720 | $21.5M | $58.0M | $41.7M | $51.8M | $67.9M | $90.1M | -$21.0M | -$7.7M |
| Fonds de Roulement | $10.4M | $53.7M | $34.9M | $71.8M | $133.8M | $178.4M | $231.1M | $207.2M | $275.9M | $397.0M |
Santé financière
| Dette / Capitaux propres | 0.50 |
| Ratio de liquidité | 6.97 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 19.98 |
Rentabilité
| Rentabilité des capitaux propres | 30.78% |
| Rentabilité du capital investi | 27.57% |
| Rentabilité des actifs | 23.54% |
| Marge brute | 64.71% |
| Marge opérationnelle | 42.26% |
| Marge nette | 32.98% |
Entreprises liées: ACAD · BLTE · CRNX · DYN · LGND · MIRM · PRAX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ADMA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions